XML 60 R44.htm IDEA: XBRL DOCUMENT v3.10.0.1
Segment and Related Information (Tables)
12 Months Ended
Jun. 30, 2018
Segment Reporting [Abstract]  
Schedule of Segment Performance Based on Income (Loss) before Interest Income and Other Income and Expense

The Company evaluates segment performance based on income (loss) before interest income and other income and expense.

 

 

Diagnostics

 

 

Other

 

 

Total

 

Year ended June 30, 2018:

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$

719.3

 

 

$

53.3

 

 

$

772.6

 

Depreciation and amortization

 

 

49.2

 

 

 

5.2

 

 

 

54.4

 

Segment operating income (loss)

 

 

139.4

 

 

 

(20.7

)

 

 

118.7

 

Year ended June 30, 2017:

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$

720.6

 

 

$

49.3

 

 

$

769.9

 

Depreciation and amortization

 

 

42.8

 

 

 

5.5

 

 

 

48.3

 

Segment operating income (loss)

 

 

129.4

 

 

 

(80.7

)

 

 

48.7

 

Year ended June 30, 2016:

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$

692.4

 

 

$

48.1

 

 

$

740.5

 

Depreciation and amortization

 

 

21.6

 

 

 

5.2

 

 

 

26.8

 

Segment operating income (loss)

 

 

225.9

 

 

 

(72.5

)

 

 

153.4

 

 

 

 

Years Ended June 30,

 

 

 

2018

 

 

2017

 

 

2016

 

Total operating income for reportable segments

 

$

118.7

 

 

$

48.7

 

 

$

153.4

 

Unallocated amounts:

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

 

1.8

 

 

 

1.2

 

 

 

0.9

 

Interest Expense

 

 

(3.2

)

 

 

(6.0

)

 

 

(0.3

)

Other

 

 

(0.4

)

 

 

(3.0

)

 

 

2.0

 

Income from operations before income taxes

 

 

116.9

 

 

 

40.9

 

 

 

156.0

 

Income tax provision

 

 

(14.0

)

 

 

20.6

 

 

 

38.8

 

Net income

 

 

130.9

 

 

 

20.3

 

 

 

117.2

 

Net loss attributable to non-controlling interest

 

 

(0.2

)

 

 

(0.2

)

 

 

 

Net income attributable to Myriad Genetics, Inc. stockholders

 

$

131.1

 

 

$

20.5

 

 

$

117.2

 

 

Schedule Of Comparison of Balance Sheet Assets by Operating Segment

The following table sets forth a comparison of balance sheet assets by operating segment:

 

 

 

June 30,

 

 

 

2018

 

 

2017

 

Net equipment, leasehold improvements and property:

 

 

 

 

 

 

 

 

Diagnostics

 

 

12.2

 

 

 

20.2

 

Other

 

 

31.0

 

 

 

30.9

 

Total

 

$

43.2

 

 

$

51.1

 

Total Assets:

 

 

 

 

 

 

 

 

Diagnostics

 

 

840.3

 

 

 

885.4

 

Other

 

 

122.5

 

 

 

124.3

 

Total

 

$

962.8

 

 

$

1,009.7

 

 

Summary of Assets by Geographical Region

The following table reconciles assets by geographical region:

 

 

 

June 30,

 

 

 

2018

 

 

2017

 

Net equipment, leasehold improvements and property:

 

 

 

 

 

 

 

 

United States

 

 

20.0

 

 

 

27.6

 

Rest of world

 

 

23.2

 

 

 

23.5

 

Total

 

$

43.2

 

 

$

51.1

 

Total Assets:

 

 

 

 

 

 

 

 

United States

 

 

852.3

 

 

 

897.3

 

Rest of world

 

 

110.5

 

 

 

112.4

 

Total

 

$

962.8

 

 

$

1,009.7

 

 

Reconciliation of Assets by Operating Segment and Geographic Region to Total Assets

The following table reconciles assets by operating segment and geographic region to total assets:

 

 

 

June 30,

 

 

 

2018

 

 

2017

 

Total assets by segment and geographical region

 

$

962.8

 

 

$

1,009.7

 

Cash, cash equivalents, and marketable investment

   securities (1)

 

 

211.3

 

 

 

199.2

 

Total

 

$

1,174.1

 

 

$

1,208.9

 

 

(1)

The Company manages cash, cash equivalents, and marketable investment securities at the consolidated level for all segments